Skip to content

Weight Loss UAE · 14 min read

Ozempic in Dubai & the UAE: Ozempic vs Wegovy, Results, Side Effects, Fake Pens and Coming Off Without Regain

A doctor's guide to Ozempic (semaglutide) for weight loss in Dubai and the UAE: Ozempic vs Wegovy, how it works, trial results, heart benefits, side effects, counterfeit warnings, Ramadan, what to eat and a step-by-step plan for coming off.

Quick answer

Ozempic is a once-weekly semaglutide injection licensed for type 2 diabetes; Wegovy is the same medicine at a higher dose (up to 2.4 mg) licensed for weight management. Semaglutide copies the gut hormone GLP-1 to reduce appetite and slow stomach emptying. In the STEP 1 trial, semaglutide 2.4 mg gave about 15% average weight loss over 68 weeks, and the SELECT trial found a 20% lower risk of heart attack, stroke or cardiovascular death in people with heart disease and overweight. Common side effects are nausea, vomiting, diarrhoea and constipation. In the UAE it is prescription-only, and health authorities have warned about counterfeit pens. Weight usually returns after stopping — in STEP 1's extension, people regained about two-thirds of the lost weight within a year — so pair it with a food-first plan and strength training from the start.

Key takeaways

  • Ozempic and Wegovy are both semaglutide; Ozempic is licensed for diabetes, Wegovy for weight management.
  • STEP 1: about 14.9% average weight loss with semaglutide 2.4 mg over 68 weeks, vs 2.4% with placebo.
  • SELECT: 20% lower risk of major heart events in people with heart disease and overweight, without diabetes.
  • WHO and the Abu Dhabi Department of Health have warned about counterfeit Ozempic — use licensed pharmacies only.
  • About two-thirds of the weight lost returned within a year of stopping in STEP 1's extension — plan your maintenance early.

Ozempic in Dubai: why the interest — and the confusion

Ozempic has become a household name in the UAE. Many people use 'Ozempic' to mean any weight-loss injection, and there is confusion about the differences between Ozempic, Wegovy, Mounjaro and compounded products. This guide explains semaglutide clearly and honestly, including how to use it safely and how to protect your results.

It does not replace your doctor's advice. For all medicine options, see weight loss injections in Dubai; for the complete UAE program, see weight loss in Dubai and the UAE.

Ozempic vs Wegovy: what is the difference?

Both contain semaglutide, but they are licensed for different purposes and doses:

Ozempic vs Wegovy: what is the difference?
OzempicWegovy
MedicineSemaglutideSemaglutide
Licensed forType 2 diabetesWeight management (and heart risk reduction in some countries)
Usual doses0.25 mg start, then 0.5 mg, up to 1–2 mg weekly0.25 mg start, increasing over about 16 weeks to 2.4 mg weekly
Weight loss in trialsModerate in diabetes trials≈ 15% average in STEP 1

How semaglutide works

Semaglutide copies GLP-1, a hormone released by the gut after meals. It acts on the brain to reduce hunger and cravings, slows the emptying of the stomach and helps the pancreas release insulin when blood sugar is high. The dose is increased step by step, usually every four weeks, to limit side effects.

Results: weight, blood sugar and the heart

Key trials of semaglutide:

  • STEP 1 (2021): adults with obesity or overweight without diabetes lost about 14.9% of body weight over 68 weeks on 2.4 mg, compared with 2.4% on placebo, alongside lifestyle advice.
  • SELECT (2023): in more than 17,000 adults with heart disease and overweight or obesity but without diabetes, semaglutide 2.4 mg reduced heart attack, stroke or cardiovascular death by 20%.
  • SUSTAIN-6 (2016): in people with type 2 diabetes at high heart risk, semaglutide reduced major cardiovascular events.
  • SURMOUNT-5 (2025): in a head-to-head trial, semaglutide gave 13.7% average weight loss vs 20.2% with tirzepatide.

Ozempic side effects

Most are digestive and settle over weeks, but can return after each dose increase:

  • Common: nausea, vomiting, diarrhoea, constipation, stomach pain, bloating, reflux and tiredness.
  • Dehydration — a real risk in UAE summers if you are vomiting or have diarrhoea.
  • Gallstones and gallbladder inflammation, and rarely pancreatitis — seek urgent care for severe, persistent stomach pain.
  • Low blood sugar when combined with insulin or sulfonylureas.
  • Muscle and nutrient loss if protein and food quality are neglected.
  • A large study of health records found higher rates of some digestive problems, including pancreatitis and bowel obstruction, in people using GLP-1 medicines for weight loss — rare, but worth knowing.

Free · 2-minute assessment

Get your free UAE weight-loss assessment & personalised plan

  • Your BMI using the right cut-off for your background
  • A realistic first weight-loss target
  • Your daily protein target
  • A personal WhatsApp reply at UAE-friendly times

Step 1 · Your body

Enter your height and weight to see your BMI, healthy weight range and protein target instantly.

Step 2 · Where should Dr. Jai's team send your plan?

Private and seen only by Dr. Jai Vora's team. This assessment is general guidance, not a diagnosis.

Who should not use Ozempic

Semaglutide is generally avoided in pregnancy, when planning pregnancy and while breastfeeding; with a personal or family history of medullary thyroid cancer or MEN2; and after pancreatitis. Extra care is needed with diabetic eye disease, gallbladder disease, kidney problems and some digestive conditions. Your doctor will assess these.

Fake Ozempic in the UAE: how to stay safe

In June 2024, the World Health Organization issued an alert about falsified Ozempic found in several countries. In February 2025, the Department of Health – Abu Dhabi warned about counterfeit Ozempic and Mounjaro sold online and via social media. The US FDA has also warned about unapproved and compounded semaglutide. Only use semaglutide prescribed by a UAE-licensed doctor and dispensed by a licensed pharmacy. Check packaging, never buy from social media, and report anything suspicious.

Ozempic and Ramadan

Diabetes and Ramadan guidelines advise planning ahead: GLP-1 medicines are best started, and doses increased, well before Ramadan rather than during it, because nausea and vomiting make dehydration more likely while fasting. People with diabetes should have a pre-Ramadan medical review. See the Ramadan diet plan for weight loss.

What to eat on Ozempic

Eat smaller meals with protein first, then vegetables, then a small portion of carbohydrates. Choose eggs, Greek yoghurt, labneh, fish, chicken, lentils, chickpeas and paneer; cooked vegetables and pulses for fibre; and 2.5–3 litres of fluid a day in the heat. Limit fried food, rich sauces, fizzy drinks, alcohol and large late meals, which worsen nausea and reflux. A sample day is in the Mounjaro in Dubai guide — the same principles apply.

Coming off Ozempic without regaining the weight

In the STEP 1 extension, people who stopped semaglutide regained about two-thirds of their lost weight within a year, and heart and blood sugar improvements faded. A planned exit gives you the best chance:

Coming off Ozempic without regaining the weight
WhenWhat to do
From the first monthProtein at every meal, strength training twice a week, no liquid sugar
3 months before stoppingPractise the plate method and portion sizes you will keep; track weight weekly
When tapering (with your doctor)Expect hunger to return; plan high-protein, high-fibre meals and snacks
First 3 months after stoppingWeekly weigh-ins; act quickly if you regain 2 kg; keep activity high
Long termRegular follow-up; re-discuss treatment with your doctor if weight returns

Alternatives to Ozempic

Not everyone needs or can use semaglutide. Many people lose 5–10% of their weight with a doctor-led diet and lifestyle plan, which already improves blood sugar, liver fat and blood pressure. Read natural alternatives to Ozempic and the Ozempic vs natural weight loss comparison.

Food-first support before, during and after Ozempic

Dr. Jai Vora is an internal medicine doctor with more than 20 years of experience in food-based weight management. He does not sell injections. He consults online from Mumbai, India, for patients across the UAE and Gulf who are considering, using or stopping semaglutide, with protein-first meal plans, side-effect strategies and a maintenance plan — while your UAE prescribing doctor manages the medicine. Take the free assessment on this page and mention Ozempic.

Frequently asked questions

Can I get Ozempic in Dubai for weight loss?

Ozempic is a prescription-only diabetes medicine in the UAE; Wegovy is the semaglutide brand licensed for weight management. Any semaglutide must be prescribed by a licensed doctor after an assessment.

What is the difference between Ozempic and Wegovy?

Both are semaglutide. Ozempic is licensed for type 2 diabetes at doses up to 1–2 mg; Wegovy is licensed for weight management at up to 2.4 mg weekly.

How much weight can you lose on Ozempic?

In STEP 1, semaglutide 2.4 mg gave about 15% average weight loss over 68 weeks. Lower diabetes doses usually give less.

What are the side effects of Ozempic?

Mostly nausea, vomiting, diarrhoea, constipation and stomach discomfort. Rarer risks include gallbladder problems and pancreatitis.

Do you regain weight after stopping Ozempic?

Most people regain some or much of the weight. In STEP 1's extension, about two-thirds was regained within a year. A food-first maintenance plan helps.

How can I tell if Ozempic is fake?

You cannot always tell by looking. Only use pens prescribed by a UAE-licensed doctor and dispensed by a licensed pharmacy, and never buy from social media or websites.

100% Virtual Clinical Care Worldwide

Get a cellular nutrition plan built on your own reports

Every consultation and diet plan is handled personally by Dr. Jai Vora, by video call and WhatsApp.

References

  1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989–1002. Source
  2. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553–1564. Source
  3. Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389:2221–2232. Source
  4. Marso SP, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN-6). N Engl J Med. 2016;375:1834–1844. Source
  5. Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393:26–36. Source
  6. European Medicines Agency. Ozempic (semaglutide) — EPAR product information. Source
  7. European Medicines Agency. Wegovy (semaglutide) — EPAR product information. Source
  8. World Health Organization. Medical Product Alert N°2/2024: Falsified Ozempic (semaglutide). 19 June 2024. Source
  9. Department of Health – Abu Dhabi. Circular No. 10/2025: Alert against the use of counterfeit versions of Ozempic and Mounjaro. 4 February 2025. Source
  10. US Food and Drug Administration. Medications containing semaglutide marketed for type 2 diabetes or weight loss. Source
  11. Sodhi M, et al. Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA. 2023;330(18):1795–1797. Source
  12. Hassanein M, et al. Diabetes and Ramadan: Practical guidelines 2021 (IDF-DAR). Diabetes Res Clin Pract. 2022;185:109185. Source
  13. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344–367. Source

This article is for education only. Speak with your doctor before changing medication, diet or treatment.

More from the Weight Loss UAE guide

← All articles